At the weekend I looked into how investments of $20,000 in a number of popular ASX shares fared over the last 10 years.
Given the success of these investments, I thought I would look at a few shares which I feel investors ought to consider investing $20,000 into today for the next decade.
Here why I think these three ASX shares could provide strong returns for investors:
Bravura Solutions Ltd (ASX: BVS)
I think that Bravura Solutions could be worth considering for a $20,000 investment. Bravura provides software and services to the wealth management and funds administration industries. Demand for its offering has been increasing other the last few years and has underpinned strong earnings growth. The good news is that it has added to its offering over the last 12 months through acquisitions. This has not only strengthened its portfolio, but opened up the company to new and lucrative markets.
iShares Global Healthcare ETF (ASX: IXJ)
Another option to consider investing $20,000 into is the iShares Global Healthcare ETF. I think this exchange traded fund could provide strong returns for investors over the 2020s thanks to the growing demand for healthcare services. This is expected to be driven by improvements in technologies, ageing populations, and increased chronic disease. The iShares Global Healthcare ETF gives investors exposure to the world's biggest and best healthcare companies. This includes the likes of CSL Ltd (ASX: CSL), Johnson & Johnson, Novartis, and Pfizer.
REA Group Limited (ASX: REA)
A final option I would put $20,000 into is REA Group. It is a leading property listings company with real estate websites in Europe, Asia, the United States, and of course Australia. Although REA Group has experienced a sizeable reduction in listings during the pandemic, it has offset its weaker revenues through cost cutting. I believe this demonstrates the resilience of its business model and positions it well to accelerate its earnings growth when the headwinds it is facing ease.
